{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T18:21:39Z","timestamp":1782498099094,"version":"3.54.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T00:00:00Z","timestamp":1554163200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003725","name":"national research foundation of Korea","doi-asserted-by":"crossref","award":["2016M3C7A1913844"],"award-info":[{"award-number":["2016M3C7A1913844"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"national research foundation of Korea","doi-asserted-by":"crossref","award":["2017R1A2B2005081"],"award-info":[{"award-number":["2017R1A2B2005081"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00259-019-04314-7","type":"journal-article","created":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T02:04:33Z","timestamp":1554170673000},"page":"1287-1298","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Clinical significance of amyloid \u03b2 positivity in patients with probable cerebral amyloid angiopathy markers"],"prefix":"10.1007","volume":"46","author":[{"given":"Hyemin","family":"Jang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Kyoung","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David John","family":"Werring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin San","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeong Sim","family":"Choe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seongbeom","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juyeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko Woon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeshin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Hyun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Joo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Charidimou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duk L.","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4262-1468","authenticated-orcid":false,"given":"Sang Won","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,2]]},"reference":[{"key":"4314_CR1","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1212\/WNL.56.4.537","volume":"56","author":"KA Knudsen","year":"2001","unstructured":"Knudsen KA, Rosand J, Karluk D, Greenberg SM. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology. 2001;56:537\u20139.","journal-title":"Neurology"},{"key":"4314_CR2","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1212\/WNL.0b013e3181dad605","volume":"74","author":"J Linn","year":"2010","unstructured":"Linn J, Halpin A, Demaerel P, Ruhland J, Giese A, Dichgans M, et al. Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology. 2010;74:1346\u201350.","journal-title":"Neurology"},{"key":"4314_CR3","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.jalz.2015.04.009","volume":"11","author":"S Martinez-Ramirez","year":"2015","unstructured":"Martinez-Ramirez S, Romero JR, Shoamanesh A, McKee AC, Van Etten E, Pontes-Neto O, et al. Diagnostic value of lobar microbleeds in individuals without intracerebral hemorrhage. Alzheimers Dement. 2015;11:1480\u20138.","journal-title":"Alzheimers Dement"},{"key":"4314_CR4","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/jcbfm.2014.43","volume":"34","author":"JC Baron","year":"2014","unstructured":"Baron JC, Farid K, Dolan E, Turc G, Marrapu ST, O\u2019Brien E, et al. Diagnostic utility of amyloid PET in cerebral amyloid angiopathy-related symptomatic intracerebral hemorrhage. J Cereb Blood Flow Metab. 2014;34:753\u20138.","journal-title":"J Cereb Blood Flow Metab"},{"key":"4314_CR5","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1212\/WNL.0000000000003197","volume":"87","author":"ME Gurol","year":"2016","unstructured":"Gurol ME, Becker JA, Fotiadis P, Riley G, Schwab K, Johnson KA, et al. Florbetapir-PET to diagnose cerebral amyloid angiopathy: a prospective study. Neurology. 2016;87:2043\u20139.","journal-title":"Neurology"},{"key":"4314_CR6","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1212\/WNL.0b013e3181cef7e3","volume":"74","author":"J Ly","year":"2010","unstructured":"Ly J, Donnan GA, Villemagne VL, Zavala J, Ma H, O\u2019Keefe G, et al. 11C-PIB binding is increased in patients with cerebral amyloid angiopathy-related hemorrhage. Neurology. 2010;74:487\u201393.","journal-title":"Neurology"},{"key":"4314_CR7","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1001\/archneur.64.3.431","volume":"64","author":"BJ Bacskai","year":"2007","unstructured":"Bacskai BJ, Frosch MP, Freeman SH, Raymond SB, Augustinack JC, Johnson KA, et al. Molecular imaging with Pittsburgh compound B confirmed at autopsy: a case report. Arch Neurol. 2007;64:431\u20134.","journal-title":"Arch Neurol"},{"key":"4314_CR8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.nicl.2017.05.002","volume":"15","author":"K Farid","year":"2017","unstructured":"Farid K, Charidimou A, Baron JC. Amyloid positron emission tomography in sporadic cerebral amyloid angiopathy: a systematic critical update. Neuroimage Clin. 2017;15:247\u201363.","journal-title":"Neuroimage Clin"},{"key":"4314_CR9","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1212\/WNL.0000000000004539","volume":"89","author":"A Charidimou","year":"2017","unstructured":"Charidimou A, Farid K, Baron JC. Amyloid-PET in sporadic cerebral amyloid angiopathy: a diagnostic accuracy meta-analysis. Neurology. 2017;89:1490\u20138.","journal-title":"Neurology"},{"key":"4314_CR10","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1212\/WNL.46.6.1592","volume":"46","author":"R Ellis","year":"1996","unstructured":"Ellis R, Olichney J, Thal L, Mirra S, Morris J, Beekly D, et al. Cerebral amyloid angiopathy in the brains of patients with Alzheimer\u2019s disease: the CERAD experience, Part XV. Neurology. 1996;46:1592\u20136.","journal-title":"Neurology"},{"key":"4314_CR11","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1136\/jnnp.49.11.1221","volume":"49","author":"MM Esiri","year":"1986","unstructured":"Esiri MM, Wilcock GK. Cerebral amyloid angiopathy in dementia and old age. J Neurol Neurosurg Psychiatry. 1986;49:1221\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4314_CR12","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1093\/jnen\/62.12.1287","volume":"62","author":"DR Thal","year":"2003","unstructured":"Thal DR, Ghebremedhin E, Orantes M, Wiestler OD. Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis\/lipohyalinosis with cognitive decline. J Neuropathol Exp Neurol. 2003;62:1287\u2013301.","journal-title":"J Neuropathol Exp Neurol"},{"key":"4314_CR13","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s00401-005-1064-y","volume":"110","author":"J Attems","year":"2005","unstructured":"Attems J, Jellinger KA, Lintner F. Alzheimer\u2019s disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy. Acta Neuropathol. 2005;110:222\u201331.","journal-title":"Acta Neuropathol"},{"key":"4314_CR14","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00401-005-1074-9","volume":"110","author":"J Attems","year":"2005","unstructured":"Attems J. Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms. Acta Neuropathol. 2005;110:345\u201359.","journal-title":"Acta Neuropathol"},{"key":"4314_CR15","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1212\/WNL.0b013e3181b23564","volume":"73","author":"A Okello","year":"2009","unstructured":"Okello A, Koivunen J, Edison P, Archer H, Turkheimer F, N\u00e5gren K, et al. Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study. Neurology. 2009;73:754\u201360.","journal-title":"Neurology"},{"key":"4314_CR16","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.neurobiolaging.2013.06.026","volume":"35","author":"JH Park","year":"2014","unstructured":"Park JH, Seo SW, Kim C, Kim SH, Kim GH, Kim ST, et al. Effects of cerebrovascular disease and amyloid beta burden on cognition in subjects with subcortical vascular cognitive impairment. Neurobiol Aging. 2014;35:254\u201360.","journal-title":"Neurobiol Aging"},{"key":"4314_CR17","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1093\/brain\/aww148","volume":"139","author":"HJ Kim","year":"2016","unstructured":"Kim HJ, Yang JJ, Kwon H, Kim C, Lee JM, Chun P, et al. Relative impact of amyloid-beta, lacunes, and downstream imaging markers on cognitive trajectories. Brain. 2016;139:2516\u201327.","journal-title":"Brain"},{"key":"4314_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1212\/WNL.0000000000001705","volume":"85","author":"HJ Kim","year":"2015","unstructured":"Kim HJ, Im K, Kwon H, Lee JM, Kim C, Kim YJ, et al. Clinical effect of white matter network disruption related to amyloid and small vessel disease. Neurology. 2015;85:63\u201370.","journal-title":"Neurology"},{"key":"4314_CR19","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1136\/jnnp-2016-314697","volume":"88","author":"G Banerjee","year":"2017","unstructured":"Banerjee G, Carare R, Cordonnier C, Greenberg SM, Schneider JA, Smith EE, et al. The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice. J Neurol Neurosurg Psychiatry. 2017;88:982\u201394.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4314_CR20","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1161\/STROKEAHA.117.016990","volume":"49","author":"SM Greenberg","year":"2018","unstructured":"Greenberg SM, Charidimou A. Diagnosis of cerebral amyloid angiopathy: evolution of the Boston criteria. Stroke. 2018;49:491\u20137.","journal-title":"Stroke"},{"key":"4314_CR21","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/ana.23845","volume":"73","author":"JH Park","year":"2013","unstructured":"Park JH, Seo SW, Kim C, Kim GH, Noh HJ, Kim ST, et al. Pathogenesis of cerebral microbleeds: in vivo imaging of amyloid and subcortical ischemic small vessel disease in 226 individuals with cognitive impairment. Ann Neurol. 2013;73:584\u201393.","journal-title":"Ann Neurol"},{"key":"4314_CR22","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7:263\u20139.","journal-title":"Alzheimers Dement"},{"key":"4314_CR23","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","volume":"12","author":"JM Wardlaw","year":"2013","unstructured":"Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822\u201338.","journal-title":"Lancet Neurol"},{"key":"4314_CR24","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3174\/ajnr.A0783","volume":"29","author":"J Linn","year":"2008","unstructured":"Linn J, Herms J, Dichgans M, Bruckmann H, Fesl G, Freilinger T, et al. Subarachnoid hemosiderosis and superficial cortical hemosiderosis in cerebral amyloid angiopathy. AJNR Am J Neuroradiol. 2008;29:184\u20136.","journal-title":"AJNR Am J Neuroradiol"},{"key":"4314_CR25","volume-title":"Seoul Neuropsychological Screening Battery (SNSB)","author":"Y Kang","year":"2003","unstructured":"Kang Y, Na DL. Seoul Neuropsychological Screening Battery (SNSB). Incheon: Human Brain Research & Consulting Co; 2003."},{"key":"4314_CR26","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1212\/WNL.43.9.1683","volume":"43","author":"F Fazekas","year":"1993","unstructured":"Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology. 1993;43:1683\u20139.","journal-title":"Neurology"},{"key":"4314_CR27","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1006\/nimg.2001.0978","volume":"15","author":"N Tzourio-Mazoyer","year":"2002","unstructured":"Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage. 2002;15:273\u201389.","journal-title":"Neuroimage"},{"key":"4314_CR28","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S1474-4422(11)70077-1","volume":"10","author":"H Barthel","year":"2011","unstructured":"Barthel H, Gertz HJ, Dresel S, Peters O, Bartenstein P, Buerger K, et al. Cerebral amyloid-beta PET with florbetaben (18F) in patients with Alzheimer\u2019s disease and healthy controls: a multicentre phase 2 diagnostic study. Lancet Neurol. 2011;10:424\u201335.","journal-title":"Lancet Neurol"},{"key":"4314_CR29","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3346\/jkms.2010.25.7.1071","volume":"25","author":"HJ Ahn","year":"2010","unstructured":"Ahn HJ, Chin J, Park A, Lee BH, Suh MK, Seo SW, et al. Seoul Neuropsychological Screening Battery-dementia version (SNSB-D): a useful tool for assessing and monitoring cognitive impairments in dementia patients. J Korean Med Sci. 2010;25:1071\u20136.","journal-title":"J Korean Med Sci"},{"key":"4314_CR30","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/ana.23830","volume":"73","author":"ME Gurol","year":"2013","unstructured":"Gurol ME, Viswanathan A, Gidicsin C, Hedden T, Martinez-Ramirez S, Dumas A, et al. Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography\/magnetic resonance imaging study. Ann Neurol. 2013;73:529\u201336.","journal-title":"Ann Neurol"},{"key":"4314_CR31","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1212\/WNL.0000000000004228","volume":"89","author":"N Raposo","year":"2017","unstructured":"Raposo N, Planton M, Peran P, Payoux P, Bonneville F, Lyoubi A, et al. Florbetapir imaging in cerebral amyloid angiopathy-related hemorrhages. Neurology. 2017;89:697\u2013704.","journal-title":"Neurology"},{"key":"4314_CR32","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/ana.21164","volume":"62","author":"KA Johnson","year":"2007","unstructured":"Johnson KA, Gregas M, Becker JA, Kinnecom C, Salat DH, Moran EK, et al. Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol. 2007;62:229\u201334.","journal-title":"Ann Neurol"},{"key":"4314_CR33","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1212\/WNL.0000000000001398","volume":"84","author":"A Charidimou","year":"2015","unstructured":"Charidimou A, Martinez-Ramirez S, Shoamanesh A, Oliveira-Filho J, Frosch M, Vashkevich A, et al. Cerebral amyloid angiopathy with and without hemorrhage: evidence for different disease phenotypes. Neurology. 2015;84:1206\u201312.","journal-title":"Neurology"},{"key":"4314_CR34","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.nicl.2016.11.008","volume":"13","author":"SW Seo","year":"2017","unstructured":"Seo SW, Ayakta N, Grinberg LT, Villeneuve S, Lehmann M, Reed B, et al. Regional correlations between [(11)C] PIB PET and post-mortem burden of amyloid-beta pathology in a diverse neuropathological cohort. Neuroimage Clin. 2017;13:130\u20137.","journal-title":"Neuroimage Clin"},{"key":"4314_CR35","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s007020200068","volume":"109","author":"KA Jellinger","year":"2002","unstructured":"Jellinger KA. Alzheimer disease and cerebrovascular pathology: an update. J Neural Transm (Vienna). 2002;109:813\u201336.","journal-title":"J Neural Transm (Vienna)"},{"key":"4314_CR36","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/ana.22516","volume":"70","author":"A Viswanathan","year":"2011","unstructured":"Viswanathan A, Greenberg SM. Cerebral amyloid angiopathy in the elderly. Ann Neurol. 2011;70:871\u201380.","journal-title":"Ann Neurol"},{"key":"4314_CR37","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1212\/WNL.0000000000000984","volume":"83","author":"A Shoamanesh","year":"2014","unstructured":"Shoamanesh A, Martinez-Ramirez S, Oliveira-Filho J, Reijmer Y, Falcone GJ, Ayres A, et al. Interrelationship of superficial siderosis and microbleeds in cerebral amyloid angiopathy. Neurology. 2014;83:1838\u201343.","journal-title":"Neurology"},{"key":"4314_CR38","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1212\/WNL.0000000000001288","volume":"84","author":"HK Na","year":"2015","unstructured":"Na HK, Park JH, Kim JH, Kim HJ, Kim ST, Werring DJ, et al. Cortical superficial siderosis: a marker of vascular amyloid in patients with cognitive impairment. Neurology. 2015;84:849\u201355.","journal-title":"Neurology"},{"key":"4314_CR39","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1212\/WNL.0000000000003220","volume":"87","author":"YJ Kim","year":"2016","unstructured":"Kim YJ, Kim HJ, Park JH, Kim S, Woo SY, Kwak KC, et al. Synergistic effects of longitudinal amyloid and vascular changes on lobar microbleeds. Neurology. 2016;87:1575\u201382.","journal-title":"Neurology"},{"key":"4314_CR40","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S1474-4422(02)00190-4","volume":"1","author":"GC Roman","year":"2002","unstructured":"Roman GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC. Subcortical ischaemic vascular dementia. Lancet Neurol. 2002;1:426\u201336.","journal-title":"Lancet Neurol"},{"key":"4314_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-16298-1","volume":"7","author":"YK Jang","year":"2017","unstructured":"Jang YK, Kim HJ, Lee JS, Kim YJ, Kim KW, Kim Y, et al. Distinctive clinical effects of haemorrhagic markers in cerebral amyloid angiopathy. Sci Rep. 2017;7:15984.","journal-title":"Sci Rep"},{"key":"4314_CR42","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1212\/WNL.58.11.1629","volume":"58","author":"LA Pfeifer","year":"2002","unstructured":"Pfeifer LA, White LR, Ross GW, Petrovitch H, Launer LJ. Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study. Neurology. 2002;58:1629\u201334.","journal-title":"Neurology"},{"key":"4314_CR43","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/ana.25123","volume":"83","author":"PA Boyle","year":"2018","unstructured":"Boyle PA, Yu L, Wilson RS, Leurgans SE, Schneider JA, Bennett DA. Person-specific contribution of neuropathologies to cognitive loss in old age. Ann Neurol. 2018;83:74\u201383.","journal-title":"Ann Neurol"},{"key":"4314_CR44","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1007\/s00259-017-3749-6","volume":"44","author":"CC Rowe","year":"2017","unstructured":"Rowe CC, Dor\u00e9 V, Jones G, Baxendale D, Mulligan RS, Bullich S, et al. 18F-Florbetaben PET beta-amyloid binding expressed in Centiloids. Eur J Nucl Med Mol Imaging. 2017;44:2053\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-019-04314-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-019-04314-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-019-04314-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T23:17:15Z","timestamp":1585696635000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-019-04314-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,2]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["4314"],"URL":"https:\/\/doi.org\/10.1007\/s00259-019-04314-7","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,2]]},"assertion":[{"value":"14 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The funders had no role in the design or conduct of the study; in the collection, management, analysis or interpretation of the data; in the preparation, review or approval of the manuscript; or in the decision to submit the manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Role of the funder"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the principles of the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}